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A novel betacoronavirus associated with lethal respira-
tory and renal complications was recently identified in pa-
tients from several countries in the Middle East. We report 
the deep genome sequencing of the virus directly from a 
patient’s sputum sample. Our high-throughput sequencing 
yielded a substantial depth of genome sequence assembly 
and showed the minority viral variants in the specimen. De-
tailed phylogenetic analysis of the virus genome (England/
Qatar/2012) revealed its close relationship to European bat 
coronaviruses circulating among the bat species of the Ves-
pertilionidae family. Molecular clock analysis showed that 
the 2 human infections of this betacoronavirus in June 2012 
(EMC/2012) and September 2012 (England/Qatar/2012) 
share a common virus ancestor most likely considerably be-
fore early 2012, suggesting the human diversity is the result 
of multiple zoonotic events.
The ability of coronaviruses (CoVs) to infect multiple species and to rapidly change through recombination 
presents a continuing human health threat. The epidem-
ic of severe acute respiratory syndrome (SARS) during 
2003–2004 during which a CoV transmitted from bats to 
civet cats and then to humans demonstrated this potential 
(reviewed in [1,2]). Recently, a novel human betacoro-
navirus (betaCoV) was found to be associated with at 
least 13 human infections, 7 of which were fatal (3–7). 
One of the viruses, EMC/2012, has been sequenced, and 
its sequence similarity to several bat CoVs suggested an 
animal origin, but a definitive bat species of origin has 
not yet been identified (3). Additional genome sequenc-
es from this virus are needed to aid diagnostics, moni-
tor population dynamics, identify the animal source, and 
characterize mechanisms of pathogenesis. The large size 
(30,000 nt) and high variability of CoV RNA genomes 
present a challenge for sequencing.
We describe a strategy for rapidly designing the prim-
ers necessary for reverse transcription and cDNA amplifi-
cation of such diverse RNA viruses and report the full-ge-
nome determination of the novel CoV directly from patient 
sputum using next-generation short-read sequencing. Full 
genomes from 2 epidemiologically unlinked novel CoV in-
fections separated in time by >2 months were analyzed to 
gain clues to 2 major questions: what are the precursors of 
the virus, and how long has the virus been circulating in its 
current form?
Materials and Methods
Primer Design
Fifteen betaCoV full genomes with the closest homol-
ogy to EMC/2012 (GenBank accession no. JX869059) 
were analyzed to identify all possible primer-like sequenc-
es (melting temperature 58°C–60°C, guanine plus cytosine 
content 35%–60%) yielding 357,198 potential primers. 
The 30-kb JX869059 CoV genome was divided into fifteen 
2.5-kb overlapping amplicons, and the 2 highest frequency 
sequences mapping in the 5′ and 3′ 250 bp of each ampli-
con were selected. Reverse complements of the 3′ mapping 
sequences were prepared, resulting in a set of 60 primers 
for the 15 amplicons (4 primers/amplicon). Three addi-
tional primers were added for the extreme termini of the 
genome. The algorithm also prepared a virtual PCR map of 
the predicted binding and amplicon size for the primer set 
on CoV genomes. A map of the primer mapping positions 
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and the predicted PCR products using EMC/2012 as the 
target is shown in Figure 1, panel A. The primer sequences 
and details of their use are listed in the online Technical 
Appendix Table (wwwnc.cdc.gov/EID/article/19/5/13-
0057-Techapp1.pdf).
Sample History
The patient, originally from Qatar, visited Saudi 
Arabia, where he became unwell with severe respiratory 
disease and renal failure and was transferred to a hospi-
tal in London, UK (4). Viral RNA was extracted from a 
sputum sample collected on September 19, 2012, sixteen 
days after symptom onset. Real-time PCR was performed 
by using an assay targeting the upE gene (6) and confirmed 
by using primers and probe targeting the RNA-dependent 
RNA polymerase (RdRp) gene. RdRpTaq1: (5′-GAC TAA 
TCG CCA GTA CCA TCA G-3′), RdRpTaq2: (5′-GAA 
CTT TGT AGT ACC AAT GAC GCA-3′), RdRpProbe: 
(5′-FAM-ATG CTT AAG TCC ATG GCT GCA ACT 
CGT GGA G–BHQ-3′). The assays gave cycle threshold 
values of 17.83–18.01 for the upE and RdRp targets. A 
100-μL sample of sputum was lysed with the addition of 
an equal volume of Qiagen Lysis Buffer AL (QIAGEN, 
Hilden. Germany). RNA was extracted from 200 µL of this 
material (final elution volume 60 µL) by using the EZ1 Vi-
rus Mini Kit v2.0 and EZ1 instrument (QIAGEN).
Reverse Transcription and PCR Amplification
Reverse transcription was performed at 50°C for 60 
min by using the amplicon reverse primers. PCRs were 
then performed with forward and reverse primers for 
each amplicon (15 reactions) for 35 cycles (98°C, 10 sec; 
54.5°C, 30 sec; 72°C, 2.5 min) with a final 10-min 72°C 
extension. A 3-µL aliquot of each reaction was analyzed 
by electrophoresis, and each reaction showed the expected 
2–2.5-kb products (Figure 1, panel B). A detailed protocol 
is available on request from the authors.
Sequencing
The PCR products of amplicons were combined into 4 
pools of approximately equal molarity and processed into 
standard Illumina multiplex libraries (Illumina, San Di-
ego, CA, USA) with each pool bearing a unique bar code 
sequence. Libraries were sequenced by Illumina MiSeq 
generating 150-bp paired end reads. The resulting Illumina 
read sets were processed to remove adaptor and primer 
sequences and quality controlled to ensure a median read 
Phred quality score of 30 by using QUASR (8). The 5′- 
and 3′-most primers were derived directly from the first 27 
nt or last 31 nt of the EMC/2012 genome. These primer 
sequences were not trimmed from the reads, which might 
mask sequence difference between EMC/2012 and Eng-
land/Qatar/2012 at these positions.
Genome Assembly
Reference-based mapping and de novo assembly meth-
ods were applied to the data for assembly into viral ge-
nomes. Reference-based mapping was performed against the 
EMC/2012 genome by using the Burrows-Wheeler Aligner 
software package [9]). For de novo assembly, maximum con-
tig lengths were obtained by using subsets of 30,000–60,000 
reads. Therefore, random subsets of reads were extracted from 
the readset and assembled by using Velvet version 1.2.07 
(10,11) and VelvetOptimiser (12). The de novo assembled 
sequences were used to confirm the validity of the reference-
based sequence and showed that the de novo assembly and 
the reference-based mapping produced identical sequences, 
apart from several small gaps near the termini of the de novo 
assembled sequence (results not shown). The complete ge-
nome sequenced here is named England/Qatar/2012 and is 
available in GenBank (accession no. KC667074).
Sequence Alignment
The complete England/Qatar/2012 genome was com-
bined with 46 previously published complete genomes of 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 19, No. 5, May 2013 737
Figure 1. A) Primers designed for reverse transcription and 
overlapping PCR amplification of the novel coronavirus (CoV). 
Dots indicate the predicted binding site of each primer along the 
EMC/2012 genome (x-axis). Gray bars indicate predicted amplicon 
lengths. Amplicon numbers are indicated beside each set of 
products. B) PCR products (3 µL of a 25-µL reaction) were resolved 
by electrophoresis on a 0.6% agarose gel and visualized by ethidium 
bromide staining. Lane M is the molecular weight marker (sizes 
indicated at left), Lanes 1–15 show the products of the amplicons 
depicted in Panel A. Lane C is the reagent PCR control.
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the α-(group 1), β-(group 2), γ-(group 3), and δ-(group 4) 
CoVs. The betaCoV complete genomes encompassed the 
a, b, c, and d lineages, as well as the 2 genomes of the 
novel human betaCoV, EMC/2012 (GenBank accession 
no. JX869059) and England1 (GenBank accession no. 
KC164505), the latter from the same patient as studied 
here. The sequences were aligned by using MUSCLE (13) 
within MEGA5 (14). Poorly aligned regions and the genes 
absent in some CoV genotypes were excluded from the 
alignment, resulting in a virtual concatenation of the open 
reading frame (ORF) 1ab, S, E, M, and N genes. A second 
alignment using a 396-bp region of the RdRp was generated 
similarly. This shorter alignment included strains that are 
genetically close to England/Qatar/2012 but lack complete 
genome sequences in GenBank.
Phylogenetic Methods
Maximum-likelihood (ML) phylogenetic trees were 
inferred from the sequence alignments by using PhyML 
version 3.0 (15). Phylogenies inferred from nucleotide and 
amino acid sequences used the general-time reversible and 
Whelan-and-Goldman substitution models, respectively. 
A discrete-γ distribution of 4 rate categories (Γ4) was used 
to model among-site heterogeneity. The robustness of the 
tree topology was assessed by bootstrap analysis of 1,000 
pseudo-replicates of the sequences.
Molecular Clock Dating
The evolutionary time scale of 2 novel human beta-
CoVs, EMC/2012 and England/Qatar/2012, was estimated 
by using a strict clock model under the Bayesian Markov 
Chain Monte Carlo framework in BEAST version 1.7.4 
(16). The Hasegawa-Kishino-Yano nucleotide substitution 
model was used with a discrete-γ distribution of 4 rate cat-
egories (Γ4) to enable among-site heterogeneity. A simple 
constant coalescent prior on the age of the divergence was 
used. With only 2 samples, estimating a rate of evolution 
was not possible, so we conditioned our date estimates on 
a range of fixed rates from 1.0 × 10−4 to 5.0 × 10-3 substitu-
tions/site/year to enable comparison with plausible values. 
For each fixed rate value, a total of 107 Bayesian Markov 
Chain Monte Carlo states were computed, with the first 
10% discarded as burn-in.
Results
Comparison of England1, England/Qatar/2012,  
and EMC/2012
The index genome for this virus, EMC/2012, was orig-
inally obtained from a Saudi Arabian patient in July 2012 
after 6 passages in cell culture (3). Our England/Qatar/2012 
sequence was derived directly from the sputum of a Qa-
tari patient receiving care in London in September 2012. A 
consensus genome from the same Qatari patient, but from 
a lower respiratory tract sample obtained later in the infec-
tion, is also available (England1, GenBank accession no. 
KC164505). The 3 genomes were aligned to determine se-
quence differences.
The England/Qatar/2012 and England1 genomes show 
only nucleotide differences at the genome termini, with 
the England1 genome lacking 46 nt at the 5′ end and 42 
nt at the 3′ end (Figure 2, panel A, Appendix, wwwnc.cdc.
gov/EID/article/19/5/13-0057-F2.htm). The England1 ge-
nome was generated by using 80 PCR products sequenced 
by Sanger dideoxy methods (17), and the high level of 
sequence identity between the England/Qatar/2012 and 
England1 sequences strongly validates the novel rapid se-
quencing methods described here.
The England/Qatar/2012 consensus genome has 
30,021 (99.67%) of 30,119 nucleotides identical to the 
EMC/2012 genome. In addition to the single nucleotide 
differences, EMC/2012 shows an insertion of 6 nt starting 
at position 29639 and a single A insertion at 30661 relative 
to the England/Qatar/2012 genome. The sequence differ-
ences are evenly spread across the genome (Figure 2, panel 
A, Appendix; Table 1).
Deep sequencing data enable the generation of a 
consensus sequence from the majority nucleotide at each 
genome position and the identification of nonconsensus 
nucleotides at each position. The England/Qatar/2012 
sample was sequenced to a high level of coverage (mean 
coverage = 4,444) compared with the previously reported 
England1 genome (2–11-fold), enabling insights into the 
variation consequent on within-host evolution. Setting a 
conservative estimate for total sequencing errors at 1% 
enables nucleotide variants present at >1% frequency to 
be considered true variants in the virus genome (Figure 2, 
panel B, Appendix). Variation is clearly detected across the 
virus genome with certain regions, such as nonstructural 
protein (NSP) NSP3, NSP5, NSP6, NSP12, and NSP14 
showing increased levels of nonconsensus nucleotides 
(Table 2).
The predicted ORFs in England/Qatar/2012 are shown 
in Figure 2, panel C, Appendix. The ORF pattern is identical 
to EMC/2012, with 1 exception: England/Qatar/2012 has a 
G at position 27162 and a longer ORF 5, whereas EMC/2012 
has an A (and the predicted ORF 5 is truncated). Van Bohee-
men et al. (3) had commented on mixed nucleotides (A–G) 
observed at this position. In addition, EMC/2012 had varia-
tion at position 11623 (U or G), whereas the England/Qa-
tar/2012 genome has a U at this position.
An assessment of specific ORFs of the 2 viral genomes 
was performed because evolution of specific proteins is a 
key determinant of host range and defines cross-species 
transmission events that may be recent for this virus. As 
expected from the overall close homology of the 2 viruses, 
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several ORFs show little or no change between the 2 ge-
nomes (Table 1). However, several ORFs show higher ami-
no acid differences, including the nucleocapsid ORF N, and 
ORFs 3, 4a, and 8b (Table 1).
Of the 16 predicted nonstructural proteins encoded by 
ORF 1a and ORF 1b, 11 show no change at the amino acid 
level (Table 1), whereas 5 (NSP2, NSP3, NSP4, NSP13, 
and NSP15) show >0.3% difference (Table 1). As more 
sequences become available from this virus, such compari-
sons will yield clues about the adaptation to humans.
Close Phylogenetic Relationship with European  
Bat CoVs
A ML phylogenetic tree inferred from the whole ge-
nome alignment indicated that the 3 novel human beta-
CoVs sequences (England1, England/Qatar/2012, and 
EMC/2012) clustered closely, forming a monophyletic lin-
eage that falls into group 2c (Figure 3, panel A, Appendix, 
wwwnc.cdc.gov/EID/article/19/5/13-0057-F3.htm). This 
novel human betaCoV lineage shares common ancestries 
with other group 2c bat CoV variants, including HKU4 and 
HKU5 strains isolated in southern People’s Republic of 
China (Figure 3, panel A, Appendix); however, the genetic 
distances between them remain substantial (≈70% similar-
ity in nucleotide level). The novel human betaCoVs have 
even less similarity with group 2a, 2b, and 2d CoVs (<60% 
nt). Phylogenies constructed from individual ORFs includ-
ing ORF 1ab, S, E, M, and N demonstrated a largely con-
sistent phylogenetic position of the novel human betaCoVs, 
except for a small discordance in the order of branching be-
tween novel human betaCoV, HKU4, and HKU5 lineages 
(Figure 3, panels B–F, Appendix). Such phylogenetic in-
congruence could result from several possible evolutionary 
features of the virus, including evolutionary rate variation, 
homoplasy, and recombination, as well as from uncertainty 
in the alignment of distant sequences. Additional related 
sequences are needed to clarify this issue.
Because more CoV strains are available in GenBank 
for partial genomic sequences, we performed extensive 
BLAST searches (www.ncbi.nlm.nih.gov/blast) and identi-
fied several additional European bat CoV sequences shar-
ing higher nucleotide sequence similarity (82.0%–87.7%) 
with the novel human betaCoVs. Because only partial RdRp 
sequences were available for these European bat CoVs, an-
other ML phylogeny was constructed from this short re-
gion to examine their evolutionary relationships (Figure 3, 
panel G, Appendix). As noted, P.pipi/VM314/2008/NLD 
(GenBank accession no. GQ259977) identified in a Pip-
istrellus pipistrellus bat from the Netherlands (18) shows 
the closest sequence similarity (87.7%) and phylogenetic 
relationship to the novel human betaCoVs. In addition, 2 
CoV sequences, H.sav/J/Spain/2007 (GenBank accession 
no. HQ184059; from Hypsugo savii, also known as P. sa-
vii) and E.isa/M/Spain/2007 (HQ184062; from Eptesicus 
isabellinus), obtained from bats from Spain (19) are also 
closely related to the novel human betaCoVs (Figure 3, 
panel G, Appendix).
Timing the Origin of Zoonosis
The time to the most recent common ancestor 
(tMRCA) of EMC/2012 (isolated June 13, 2012) and 
England/Qatar/2012 (isolated September 19, 2012) was 
estimated with a strict molecular clock model. A plot of 
estimated tMRCA of the 2 human strains as a function of 
the fixed rate of molecular evolution shows that with the 
fastest measured rate of human CoVs (2 × 10-3 substitutions/
site/year for SARS-CoV [20]) the tMRCA (i.e., October 
2011; 95% highest posterior density: August–December 
2011) is older than the start of 2012, but with slower rates 
it is calculated to be much older (Figure 4 [20,21–23]). 
However, for evolutionary rates as high as those of human 
influenza A virus and HIV (e.g., 3–5 × 10-3 substitutions/
site/year), the estimated tMRCA becomes compatible with 
the earliest disease report in Jordan in April 2012 (7).
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Table 1. Nucleotide and amino acid differences between novel 
human betacoronaviruses EMC/2012 and England/Qatar/2012 
major ORFs 
ORF* 
Nucleotide  Amino acid 
Difference† 
Change, 
%‡ 
 
Difference† 
Change, 
%‡§ 
ORF 3 4 1.28  2 1.92 
N 11 0.86  4 0.94 
ORF 8b 2 0.59  1 0.88 
ORF 4a 3 0.88  1 0.88 
NSP13 4 0.24  4 0.71 
NSP2 7 0.35  4 0.61 
NSP15 3 0.29  2 0.58 
ORF 5 3 0.44  1 0.44 
NSP3 21 0.37  8 0.42 
NSP4 3 0.20  2 0.39 
ORF 4b 4 0.46  1 0.34 
ORF 1a 45 0.34  14 0.32 
S 10 0.24  2 0.15 
ORF 1b 15 0.19  3 0.11 
E 0 0.00  0 0.00 
M 0 0.00  0 0.00 
NSP1 2 0.35  0 0.00 
NSP5 2 0.22  0 0.00 
NSP6 4 0.46  0 0.00 
NSP7 1 0.40  0 0.00 
NSP8 1 0.17  0 0.00 
NSP9 3 0.91  0 0.00 
NSP10 1 0.24  0 0.00 
NSP11 0 0.00  0 0.00 
NSP12 4 0.14  0 0.00 
NSP14 3 0.19  0 0.00 
NSP16 1 0.11  0 0.00 
*ORF nomenclature is from van Boheemen et al. (3). ORF, open reading 
frame; NSP, nonstructural protein. 
†No. nucleotide or amino acid differences between aligned ORF or their 
predicted protein products. 
‡No. differences (nucleotide or amino acid) divided by the length of the 
ORF or the predicted protein. 
§ORFs were sorted by decreasing amino acid percentage change. 
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Discussion
The reports of several human infections by similar 
strains of a novel betaCoV have raised global concern 
about a new SARS-like outbreak. Such worry is not mis-
placed, particularly when little is known about the origin 
and transmissibility of the virus and the natural history of 
the disease it causes. In this study, we presented a rapid 
deep sequencing method to obtain the complete genome 
sequence of the novel human betaCoV and its minor vari-
ants from a patient’s sputum sample, which provides a use-
ful tool to study the origin, evolution, and detection of this 
novel CoV. Our detailed phylogenetic analyses of the viral 
genomes also provide additional clues to the emergence 
and evolution of this virus.
Mammalian zoonoses are often identified as the ori-
gin of new human CoV infections including OC43, NL63, 
and SARS-CoVs (24–27). In particular, bats, which main-
tain the largest diversity of CoVs (28), are thought to be a 
natural reservoir of the virus and thus a probable origin of 
the novel human betaCoV studied here. Indeed, the initial 
genetic study of the novel human betaCoV demonstrated 
its phylogenetic relatedness to the HKU5 and HKU4 bat 
CoVs in southern China (5). van Boheemen et al. found 
a bat CoV sequence from the Netherlands that clusters 
closely with EMC/2012 (3). In addition, most bat CoVs 
in the group 2c lineage, including the sequence from the 
Netherlands, were isolated from bat species of the Vesper-
tilionidae family, whereas the SARS-like CoVs in group 
2b lineage were mainly from bats from the Rhinolophidae 
family (29). In this study, we showed that 2 other CoVs 
from bats from Spain of Vespertilionidae again are also 
clustered near the novel human betaCoVs (Figure 3, panel 
G, Appendix), which further supports a European Vesper-
tilionidae bat ancestry for this virus. However, such a ge-
nealogic link may be indirect and distant because a similar 
hypothesis for SARS-CoV has been under dispute: whether 
the CoV jumped from bats directly to humans or through 
civets or even through some other animals as intermediate 
hosts (30). Therefore, like SARS-CoV, the high dissimi-
larity between the bat CoVs and novel human betaCoVs 
makes it difficult to rule out the presence of other interme-
diate hosts transferring the virus from bats to humans and 
to confirm the geographic origin of the direct predecessor. 
With the current data, Europe and the Middle East would 
be plausible regions for more intensive pilot surveillance 
studies on bats and other animal reservoirs for this virus.
In the interest of public health, it is critical to deter-
mine whether these CoV infections in humans are the 
consequence of a single zoonotic event followed by ongo-
ing human-to-human transmissions or whether the 3 geo-
graphic sites of infection (Jordan, Saudi Arabia, and Qa-
tar) represent independent transmissions from a common 
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Table 2. Nonconsensus variants detected in the sequence of a novel human betacoronavirus 
Name* Start† End >0.01–0.05‡ >0.05–0.1 >0.1 Total§ Length %¶# 
NSP9 12659 12988 3 0 0 3 329 0.91 
NSP10 12989 13408 3 0 0 3 419 0.72 
NSP14 18001 19572 6 1 1 8 1571 0.51 
NSP6 10937 11812 4 0 0 4 875 0.46 
NSP3 2837 8497 25 0 0 25 5660 0.44 
NSP12 13432 16206 11 1 0 12 2774 0.43 
NSP7 11813 12061 1 0 0 1 248 0.40 
NSP5 10019 10936 3 0 0 3 917 0.33 
N 28565 29806 4 0 0 4 1241 0.32 
S 21455 25516 12 0 1 13 4061 0.32 
ORF 4a 25851 26180 1 0 0 1 329 0.30 
M 27852 28511 2 0 0 2 659 0.30 
ORF 8b 28761 29099 1 0 0 1 338 0.30 
NSP13 16307 18000 5 0 0 5 1693 0.30 
NSP4 8498 10018 4 0 0 4 1520 0.26 
NSP2 857 2836 4 0 0 4 1979 0.20 
NSP8 12062 12658 1 0 0 1 596 0.17 
ORF 4b 26092 26832 0 1 0 1 740 0.14 
NSP15 19573 20601 1 0 0 1 1028 0.10 
NSP1 278 856 0 0 0 0 578 0.00 
NSP11 13409 13453 0 0 0 0 44 0.00 
NSP16 20602 21513 0 0 0 0 911 0.00 
ORF 3 25531 25842 0 0 0 0 311 0.00 
ORF 5 26839 27513 0 0 0 0 674 0.00 
E 27589 27837 0 0 0 0 248 0.00 
*ORF nomenclature is from van Boheemen et al. (3). ORF, open reading frame; NSP, nonstructural protein. 
†Nucleotide position in England/Qatar/2012 genome. 
‡No. nucleotide positions showing the indicated fraction of nonconsensus nucleotides. Only positions with a minimum of 1,000-fold coverage and a Phred 
quality score of 30 were included. 
§No. nucleotide positions with >0.01 (1%) nonconsensus nucleotides. 
¶Total no. positions with variation divided by length of ORF)  100. 
#ORFs were sorted by decreasing amino acid percentage change. 
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nonhuman reservoir. The large genetic diversity of CoV 
maintained in animal reservoirs suggests that viruses that 
independently moved to humans from animals at different 
times and places are likely to be reasonably dissimilar in 
their genomes, possibly making the multiple transmission 
events model less likely. Further information is needed to 
confirm this point because the currently available data are 
limited. If we calibrate our molecular clock analysis us-
ing the evolutionary rate of Zhao et al. (20) estimated for 
SARS-CoV, we dated the tMRCA of EMC/2012 and Eng-
land/Qatar/2012 viruses to early 2011. Therefore, if both 
sequenced viruses and the other cases descended from a 
single zoonotic event, then this tMRCA suggests that the 
novel virus has been circulating in human population for 
>1 year without detection and would suggest most infec-
tions were mild or asymptomatic. The rate would have to 
be considerably faster, of a magnitude observed for human 
influenza A virus, for the tMRCA to be compatible with 
the earliest known cases in April 2012. Perhaps more prob-
able, therefore, is that the 13 known cases of this disease 
represent >1 independent zoonotic transmission from an 
unknown source. Viral sequence data from other patients 
infected with this novel human betaCoV will help to more 
accurately estimate the estimate a genomic evolutionary 
rate specific to this virus, which will then yield a tMRCA 
estimate closer to the actual time.
A major determinant of SARS pathology is the distri-
bution of the host receptor that the virus has evolved to use 
for entry. A detailed analysis of EMC/2012 receptor use 
in cell culture (31) revealed that EMC/2012 was capable 
of infecting a range of mammalian cells, including human, 
pig, and bat cells, and the virus entry was independent of 
the ACE2 receptor. Comparing the S genes of England/Qa-
tar/2012 predicts only 2 aa changes (in a 1,367-residue pro-
tein). Thus, this broad infection capability of EMC/2012 is 
likely to be valid for England/Qatar/2012 and would imply 
a higher possibility for the existence of other intermediate 
hosts transferring the virus from bats to humans.
Precise identification of the origin of this virus, defin-
ing its mode of evolution, and determining the mechanisms 
of viral pathogenesis will require full-genome sequences 
from all cases of human infection and substantially more 
sampling and sequencing from Vespertilionidae bats and 
other related animals. The sequencing method reported 
here markedly shortens the time required to process the 
clinical sample to genome assembly to 1 week and will 
provide a useful tool to study this novel virus.
Note added in proof. The current number of con-
firmed novel CoV cases is 17, including 11 deaths (www. 
who.int/csr/don/2013_02_21/en/index.html). An analysis 
of the 4 novel CoV genomes now available suggests an 
evolution rate of 1.77 × 10–3 substitutions/site/year, which 
would give a tMRCA of mid-2011. The analysis is online 
(http://epidemic.bio.ed.ac.uk/ coronavirus_analysis).
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Figure 4. tMRCA analysis across a 
range of fixed evolutionary rates. The 
tMRCA of EMC/2012 and England/
Qatar/2012 estimated from fixing a 
range of genomic evolutionary rates 
(1 × 10−4, 2 × 10−4, 5 × 10−4, 1 × 10–3, 
2 × 10–3, and 5 × 10–3 substitutions/
site/year) are shown in data points 
with vertical error bars (95% highest 
posterior density). Evolutionary rate 
estimates of human CoV genome and 
genes in the literature are indicated at 
the bottom of the plot (mean or point 
estimate as a dot, 95% CIs of estimate 
as a square bracket). tMRCA, time to 
the most recent common ancestor; 
CoV, coronavirus; SARS, severe 
acute respiratory syndrome; ORF, 
open reading frame.
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Figure 2. A) Sequence differences among EMC/2012, England/Qatar/2012 and England1. The sequences of the 3 genomes were aligned, 
and differences between the sequence of England/Qatar/2012 and England1 (upper row) or EMC/2012 and England1 (lower row) were 
tabulated. The colored vertical ticks indicate nucleotide differences (change to A: red, change to T: dark red, change to G: indigo, change 
to C: medium blue, gap: gray). B) Non-consensus variants detected in the virus sample. The Illumina readset (Illumina, San Diego, CA, 
USA) for England/Qatar/2012 was mapped to the England/Qatar/2012 genome. Nucleotide positions showing nucleotides that differed 
from the consensus were tabulated. Colored dots indicate nucleotide positions with >1%–5% (gray), >5%–10% (orange), and >10% (red) 
nonconsensus variants. Positions with >5% variation and observed nucleotides are as follows: 14311: T, 92.07; G, 7.81; C, 0.12. 18460: 
C, 94.03; T, 5.97. 18692: G, 85.35; T, 14.65. 22385: G, 83.59; A, 16.41; C, 0.01. 26554: A, 90.85; G, 9.00; T, 0.15. C) Open reading frame 
(ORF) analysis of England/Qatar/2012. The positions of stop codons in each of the 3 forward ORFs are indicated by vertical black lines; 
the presence of ORFs of >75 aa are indicated by a closed box. ORF nomenclature is from Van Boheemen et al. (3).
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Figure 3. Phylogenetic analyses of coronaviruses. A–F) Maximum-likelihood phylogenies of combined and each individual open 
reading frame (ORF), including ORF 1ab, S, E, M, and N. Previously defined viral lineages (group 1, 2a, 2b, 2c, 2d, 3, and 4) are 
highlighted by color blocks and described in (A). F) Phylogenetic analyses on the partial RNA-dependent RNA polymerase sequence 
region (396 bp) of coronaviruses (CoVs). Partial gene sequences from other CoVs that are closely related to the novel human 
betaCoVs are included and marked with asterisks. Bootstrap analysis of 1,000 replicates was performed for each phylogeny. The 
novel human betaCoVs studied here are shown in red. Scale bar indicates nucleotide substitutions per site.
